Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertension

Citation
Yt. Lee et al., Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertension, GASTROIN EN, 50(1), 1999, pp. 47-52
Citations number
26
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
GASTROINTESTINAL ENDOSCOPY
ISSN journal
00165107 → ACNP
Volume
50
Issue
1
Year of publication
1999
Pages
47 - 52
Database
ISI
SICI code
0016-5107(199907)50:1<47:UOCDEI>2.0.ZU;2-I
Abstract
Background: Azygos blood flow is an index of blood flow through gastroesoph ageal collateral vessels and varices in portal hypertension. Conventional m easurement of azygos blood flow involves catheterization of the azygos vein . We studied the feasibility of assessing azygos blood flow with color Dopp ler endosonography and of monitoring the effects of vasoactive agents on az ygos blood flow. Methods: Patients with portal hypertension were examined by means of linear array color Doppler endoscopic ultrasonography (EUS). Patients who had tak en propranolol or nitrates in the 4 weeks before the day of measurement of azygos blood flow were excluded. After identification of the azygos vein an d recording of baseline readings of mean arterial blood pressure, pulse rat e, and azygos blood flow, patients were selected in a random manner to rece ive a bolus injection of 2 mg terlipressin, 250 mu g somatostatin, or salin e solution (control). Azygos blood flow was measured 1, 5, and 10 minutes a fter injection (AzBF-1,AzBF-5, AzBF-10). Results: Six patients were recruited in each treatment group. Basal azygos blood flow showed a positive association with the Child-Pugh grade of cirrh osis (p < 0.005). After bolus injection of terlipressin and somatostatin, t here was a marked decrease in AzBF-1 (24% and 37%), AzBF-5 (42% and 19%), a nd AzBF-10 (40% both) compared with baseline. The control group showed no s ignificant change in azygos blood flow. Conclusions: Color Doppler EUS is useful in assessing azygos blood flow in portal hypertension and in monitoring the effects of vasoactive agents.